Cardiff Oncology, Inc.
DE ˙ DB ˙ US14147L1089
1,13 € ↓ -0,10 (-7,78%)
2026-06-04
AKTIENPREIS
SecurityDE:XE7C / Cardiff Oncology, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership493,205 shares
Latest Disclosed Value $ 798,993
Northern Trust Corp reports 6.81% increase in ownership of XE7C / Cardiff Oncology, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 493,205 shares of Cardiff Oncology, Inc. (DE:XE7C) valued at $646,099 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 461,753 shares of Cardiff Oncology, Inc.. This represents a change in shares of 6.81% during the quarter. The current value of the position is $555,349 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F CARDIFF ONCOLOGY COM 14147L108 493,205 31,452 6.81 799 -38.47 0.0000
2026-02-17 2025-12-31 13F CARDIFF ONCOLOGY COM 14147L108 461,753 -57,999 -11.16 1,298 21.21 0.0002
2025-11-14 2025-09-30 13F CARDIFF ONCOLOGY COM 14147L108 519,752 -204,699 -28.26 1,071 -53.11 0.0001
2025-08-13 2025-06-30 13F CARDIFF ONCOLOGY COM 14147L108 724,451 240,087 49.57 2,282 50.13 0.0003
2025-05-13 2025-03-31 13F CARDIFF ONCOLOGY COM 14147L108 484,364 147,272 43.69 1,521 3.97 0.0002
2025-02-14 2024-12-31 13F CARDIFF ONCOLOGY COM 14147L108 337,092 27,489 8.88 1,463 77.00 0.0002
2024-11-13 2024-09-30 13F CARDIFF ONCOLOGY COM 14147L108 309,603 211,160 214.50 827 278.90 0.0001
2024-08-14 2024-06-30 13F CARDIFF ONCOLOGY COM 14147L108 98,443 12,930 15.12 219 -52.19 0.0000
2024-05-14 2024-03-31 13F CARDIFF ONCOLOGY COM 14147L108 85,513 14,127 19.79 457 334.29 0.0001
2024-02-13 2023-12-31 13F CARDIFF ONCOLOGY COM 14147L108 71,386 0 0.00 106 6.06 0.0000
2023-11-13 2023-09-30 13F CARDIFF ONCOLOGY COM 14147L108 71,386 -1,000 -1.38 99 -6.60 0.0000
2023-08-11 2023-06-30 13F CARDIFF ONCOLOGY COM 14147L108 72,386 1,963 2.79 106 -8.62 0.0000
2023-05-15 2023-03-31 13F CARDIFF ONCOLOGY COM 14147L108 70,423 1,039 1.50 116 19.59 0.0000
2023-02-13 2022-12-31 13F CARDIFF ONCOLOGY COM 14147L108 69,384 0 0.00 97 -9.35 0.0000
2022-11-14 2022-09-30 13F CARDIFF ONCOLOGY COM 14147L108 69,384 2,792 4.19 107 -27.21 0.0000
2022-08-12 2022-06-30 13F CARDIFF ONCOLOGY COM 14147L108 66,592 -251,266 -79.05 147 -81.35 0.0000
2022-05-13 2022-03-31 13F CARDIFF ONCOLOGY COM 14147L108 317,858 -21,223 -6.26 788 -61.33 0.0001
2022-02-08 2021-12-31 13F CARDIFF ONCOLOGY COM 14147L108 339,081 15,375 4.75 2,038 -5.47 0.0003
2021-11-15 2021-09-30 13F CARDIFF ONCOLOGY COM 14147L108 323,706 5,861 1.84 2,156 1.99 0.0004
2021-08-13 2021-06-30 13F CARDIFF ONCOLOGY COM 14147L108 317,845 271,248 582.11 2,114 390.49 0.0004
2021-05-12 2021-03-31 13F CARDIFF ONCOLOGY COM 14147L108 46,597 2,077 4.67 431 -46.19 0.0001
2021-02-11 2020-12-31 13F CARDIFF ONCOLOGY COM 14147L108 44,520 19,703 79.39 801 127.56 0.0002
2020-11-16 2020-09-30 13F CARDIFF ONCOLOGY COM 14147L108 24,817 13,475 118.81 352 517.54 0.0001
2020-08-14 2020-06-30 13F CARDIFF ONCOLOGY COM 14147L108 11,342 11,342 57 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.